Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murat Kurt

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Medical Economics|March 12, 2024
Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspectiveThor-Henrik Brodtkorb, Christopher Knight, Farzam Kamgar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2024
Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 TrialsJeffrey S Weber, Mark R Middleton, Georgia Yates, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2025
Radiological progression-free survival as a surrogate for overall survival in patients with metastatic hormone-sensitive prostate cancer: A bivariate meta-analysisNeal Shore, Alicia K Morgans, Martin Boegemann, et al.
Leukemia Research|October 9, 2025
Evaluating complete response/remission rate as a surrogate endpoint in relapsed/refractory chronic lymphocytic leukemiaLin Wang, Murat Kurt, Tim Disher, et al.
Turkish Neurosurgery|October 9, 2013
Does probe's eye subthalamic nucleus length on T2W MRI correspond with microelectrode recording in patients with deep brain stimulation for advanced Parkinson's disease?Ersoy Kocabicak, Dursun Aygun, Ilkay Ozaydin, et al.
MDM Policy & Practice|March 31, 2022
Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced MelanomaVictoria Federico Paly, Murat Kurt, Lirong Zhang, et al.
Journal of Comparative Effectiveness Research|July 11, 2023
Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinomaSvenja Petersohn, Bradley McGregor, Sven L Klijn, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 21, 2017
From Data to Improved Decisions: Operations Research in Healthcare DeliveryMuge Capan, Anahita Khojandi, Brian T Denton, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Medical Economics|March 12, 2024
Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspectiveThor-Henrik Brodtkorb, Christopher Knight, Farzam Kamgar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2024
Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 TrialsJeffrey S Weber, Mark R Middleton, Georgia Yates, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2025
Radiological progression-free survival as a surrogate for overall survival in patients with metastatic hormone-sensitive prostate cancer: A bivariate meta-analysisNeal Shore, Alicia K Morgans, Martin Boegemann, et al.
Leukemia Research|October 9, 2025
Evaluating complete response/remission rate as a surrogate endpoint in relapsed/refractory chronic lymphocytic leukemiaLin Wang, Murat Kurt, Tim Disher, et al.
Turkish Neurosurgery|October 9, 2013
Does probe's eye subthalamic nucleus length on T2W MRI correspond with microelectrode recording in patients with deep brain stimulation for advanced Parkinson's disease?Ersoy Kocabicak, Dursun Aygun, Ilkay Ozaydin, et al.
MDM Policy & Practice|March 31, 2022
Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced MelanomaVictoria Federico Paly, Murat Kurt, Lirong Zhang, et al.
Journal of Comparative Effectiveness Research|July 11, 2023
Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinomaSvenja Petersohn, Bradley McGregor, Sven L Klijn, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 21, 2017
From Data to Improved Decisions: Operations Research in Healthcare DeliveryMuge Capan, Anahita Khojandi, Brian T Denton, et al.
Pageof 5